Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Psychedelic Drugs Market Value Growth And Long-Term Outlook
The psychedelic drugs market size has seen rapid expansion in recent years. This market is expected to grow from $6.33 billion in 2025 to $7.37 billion in 2026, at a compound annual growth rate (CAGR) of 16.4%. The historical growth for this sector can be ascribed to a high unmet need in depression treatment, foundational academic research on psychedelics, their application in underground and compassionate use cases, the limited efficacy of conventional antidepressants, and a rising awareness of mental health.
The psychedelic drugs market size is projected to experience substantial growth in the next few years. It is anticipated to expand to $13.67 billion in 2030, achieving a compound annual growth rate (CAGR) of 16.7%. This expansion during the forecast period can be attributed to factors such as regulatory approvals for medical applications, growing adoption by psychiatrists, the broadening of the indication pipeline, improved patient outcomes data, and strategic partnerships established between biotech firms and healthcare providers. Key trends expected in the forecast period include the expansion of psychedelic-assisted therapy programs, an increase in clinical trials for mental health indications, a growing acceptance of alternative psychiatry treatments, clarification of regulatory pathways for controlled substances, and rising investment from venture capital and pharmaceutical players.
Get A Free Sample Report With In-Depth Market Insights:
Psychedelic Drugs Market Expansion Drivers: What’s Shaping Future Growth?
The rising prevalence of mental health conditions is anticipated to fuel the expansion of the psychedelic drugs market in the foreseeable future. Mental illnesses encompass health states characterized by alterations in emotion, thinking, or behavior, including conditions such as distress and post-traumatic stress disorder. Psychedelic drugs are utilized for the treatment of depression and post-traumatic stress disorder, and their regular usage contributes to a decrease in mental illnesses. For instance, in November 2023, according to the National Health Service, a UK-based government department, in 2023, approximately one in five individuals aged 8 to 25 years were estimated to have a probable mental disorder, affecting 20.3% of 8 to 16-year-olds, 23.3% of 17 to 19-year-olds, and 21.7% of 20 to 25-year-olds. Consequently, the increasing number of mental illness cases is a driving force behind the growth of the psychedelic drugs market.
Psychedelic Drugs Market Segments: Where Is Growth Concentrated?
The psychedelic drugs market covered in this report is segmented –
1) By Type: Lysergic Acid Diethylamide (LSD), Ketamine, Phencyclidine, Gamma Hydroxybutyric Acid (GHB), Salvia
2) By Disease Indication: Depression, PTSD
3) By Origin: Natural, Synthetic
4) By Application: Treatment-Resistant Depression, Opiate addiction, Post- Traumatic Stress Disorder, Narcolepsy, Panic Disorders
5) By Distribution Channel: Hospitals Pharmacy, Retail Pharmacy, Online Pharmacy
Subsegments:
1) By Lysergic Acid Diethylamide (LSD): LSD Tablets, LSD Liquid, LSD Blotters
2) By Ketamine: Ketamine Infusion, Ketamine Nasal Spray, Ketamine Injectable
3) By Phencyclidine (PCP): PCP Powder, PCP Tablets, PCP Liquid
4) By Gamma Hydroxybutyric Acid (GHB): GHB Liquid, GHB Powder, GHB Capsules
5) By Salvia: Salvia Extract, Salvia Dried Leaves, Salvia Tinctures
Psychedelic Drugs Market Strategic Trends: What Defines The Next Growth Phase?
Leading companies in the psychedelic drugs market are prioritizing the creation of innovative solutions, such as pharmaceutical-grade psilocybin formulations, to boost therapeutic effectiveness, ensure user safety, and broaden treatment possibilities for mental health disorders. A pharmaceutical-grade psilocybin formulation signifies psilocybin produced and standardized to pharmaceutical quality, guaranteeing consistent purity, potency, and safety for medical applications. For example, in September 2025, Optimi Health, an Australia-based psychedelic therapeutics company, introduced its natural psilocybin capsules in Australia specifically for treating TRD. With this product launch, Optimi Health aims to provide a clinically validated treatment option for individuals, strengthen its position in the Australian mental health market, and expedite the acceptance of psychedelic-assisted therapies.
Psychedelic Drugs Market Key Participants And Competitive Landscape
Major companies operating in the psychedelic drugs market are Atai Life Sciences, Cybin Inc., Mind Medicine Inc., Compass Pathways, Seelos Therapeutics, Numinus Wellness Inc., GH Research, Revive Therapeutics, Havn Life Sciences, PharmaTher Holdings, Field Trip Health, Small Pharma, Incannex Healthcare, Optimi Health, NeonMind Biosciences, Entheon Biomedical, Mydecine Innovations Group, Red Light Holland, Eleusis, MAPS Public Benefit Corporation, Beckley Psytech, Awakn Life Sciences, Psygen Industries, Enveric Biosciences, Filament Health, Tactogen, Bexson Biomedical, BetterLife Pharma, Clairvoyant Therapeutics, Universal Ibogaine
View The Full Psychedelic Drugs Market Report:
Psychedelic Drugs Market Geographic Analysis: Where Is Demand Accelerating Fastest?
North America was the largest region in the psychedelic drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the psychedelic drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
